Norbert G. Riedel

Companies

• Eton Pharmaceuticals, Inc.Board member Nov 13, 2018 to now¹
• Jazz PharmaceuticalsBoard member May 9, 2013 to now²
• Cerevel Therapeutics Holdings, Inc.Board member Oct 30, 2020 to Aug 5, 2024³
• Aptinyx Inc.Chair Jan 5, 2023 to Jan 5, 2023⁴
• Aptinyx Inc.Board member Jun 20, 2018 to Dec 8, 2021⁵
• Aptinyx Inc.Chief executive officer Jun 20, 2018 to Dec 8, 2021⁵
• Aptinyx Inc.President Jun 20, 2018 to Feb 28, 2020⁵
• ARIAD PharmaceuticalsBoard member May 2, 2011 to Feb 16, 2017⁶
• Baxter InternationalCorporate Vice President Jul 7, 2003 to Jan 18, 2013⁷
• Genome Therapeutics CorporationBoard member Jun 12, 2006 to Jun 13, 2008⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EPEton Pharmaceuticals, Inc. ETON224,300 shares⁹$11.1M at $49.62Apr 22, 2026
• JPJazz Pharmaceuticals JAZZ17,553 shares¹⁰$3.6M at $207.05Sep 2, 2026
• Baxter International BAX56,689 shares¹¹$1.4M at $24.74Jan 16, 2013
• AAptinyx Inc.620,383 shares¹²Dec 8, 2021
• CTCerevel Therapeutics Holdings, Inc.0 shares¹³Aug 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 31, 2026Shares withheld for tax 1,692 shares at $241.39 of Jazz Pharmaceuticals¹⁰
• Aug 31, 2026Shares withheld for tax 14 shares at $244.64 of Jazz Pharmaceuticals¹⁰
• Aug 5, 2026Granted 1,605 shares of Jazz Pharmaceuticals¹⁴
• Apr 21, 2026Exercised options 19,655 shares at $8.61 of Eton Pharmaceuticals, Inc.⁹
• Apr 21, 2026Exercised options 12,500 shares at $7.31 of Eton Pharmaceuticals, Inc.⁹
• Feb 27, 2026Sold 3,415 shares at $192.00 of Jazz Pharmaceuticals¹⁵
• Feb 27, 2026Exercised options 3,415 shares at $138.08 of Jazz Pharmaceuticals¹⁵
• Feb 3, 2026Exercised 30,000 shares at $4.42 of Eton Pharmaceuticals, Inc.¹⁶
• Aug 8, 2025Shares withheld for tax 1,805 shares at $111.25 of Jazz Pharmaceuticals¹⁷
• Aug 7, 2025Granted 3,507 shares of Jazz Pharmaceuticals¹⁷
• Jan 3, 2025Exercised options 25,000 shares at $3.47 of Eton Pharmaceuticals, Inc.¹⁸
• Jan 3, 2025Exercised options 50,000 shares at $3.78 of Eton Pharmaceuticals, Inc.¹⁸
• Jan 3, 2025Exercised options 27,400 shares at $3.58 of Eton Pharmaceuticals, Inc.¹⁸
• Aug 6, 2024Shares withheld for tax 1,484 shares at $111.35 of Jazz Pharmaceuticals¹⁹
• Aug 2, 2024Granted 3,731 shares of Jazz Pharmaceuticals¹⁹
• Aug 1, 2024Returned to company 10,461 shares of Cerevel Therapeutics Holdings, Inc.¹³
• Aug 1, 2024Returned to company 46,092 shares of Cerevel Therapeutics Holdings, Inc.¹³
• Jun 5, 2024Granted 10,461 shares of Cerevel Therapeutics Holdings, Inc.²⁰
• Aug 14, 2023Sold 1,241 shares at $138.16 of Jazz Pharmaceuticals²¹
• Aug 11, 2023Granted 3,075 shares of Jazz Pharmaceuticals²¹
• Jun 7, 2023Granted 3,282 shares of Cerevel Therapeutics Holdings, Inc.²²
• Aug 8, 2022Sold 1,089 shares at $152.32 of Jazz Pharmaceuticals²³
• Aug 5, 2022Granted 2,561 shares of Jazz Pharmaceuticals²³
• Aug 5, 2022Sold 8,000 shares at $155.87 of Jazz Pharmaceuticals²³
• Aug 5, 2022Exercised options 8,000 shares at $55.28 of Jazz Pharmaceuticals²³